FDA Allows More Cancer Drug Imports from China Amid Shortage (1)

US regulators are allowing imports of additional supplies of a cancer drug from China amid a nationwide shortage that has forced doctors to ration care, putting patients’ lives at risk.

The Food and Drug Administration has allowed distribution of 10 more lots of cisplatin, an essential chemotherapy drug, from Qilu Pharmaceutical Co., an agency spokesperson said Monday. The FDA previously cleared four lots of Qilu’s version of the drug, which is unapproved in the US, but similar to approved cisplatin sold there.

The 10 new lots will arrive in the US this week, said a spokesperson for Apotex ...